Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
G100 Companies is a private partnership of boutique businesses that provide specialized solutions and peer-learning communities for CEOs and corporate boards. Its flagship business, the G100 Network, is an exclusive membership organization for the CEOs of the world's largest and most significant companies, facilitating high-level executive exchange. The firm also includes SSA & Company, a management consulting firm focused on operational excellence and digital transformation, and Highline, which provides executive education. In 2020, the G100 Network was acquired by World 50, another prominent peer-membership organization for senior executives. While the company serves many leaders in the healthcare and life sciences sectors, it is not a biotechnology or pharmaceutical developer itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on G100 Companies.